Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dora E Wiskirchen

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Antimicrobial Agents and Chemotherapy|October 19, 2011
In vitro pharmacodynamics of vancomycin and cefazolin alone and in combination against methicillin-resistant Staphylococcus aureusMao Hagihara, Dora E Wiskirchen, Joseph L Kuti, et al.
Pharmacotherapy|February 13, 2013
Comparative pharmacokinetics, pharmacodynamics, and tolerability of ertapenem 1 gram/day administered as a rapid 5-minute infusion versus the standard 30-minute infusion in healthy adult volunteersDora E Wiskirchen, Seth T Housman, Richard Quintiliani, et al.
Antimicrobial Agents and Chemotherapy|April 27, 2011
In vivo efficacy of a human-simulated regimen of ceftaroline combined with NXL104 against extended-spectrum-beta-lactamase (ESBL)-producing and non-ESBL-producing EnterobacteriaceaeDora E Wiskirchen, Jared L Crandon, Guilherme H Furtado, et al.
Antimicrobial Agents and Chemotherapy|February 2, 2011
In vitro pharmacodynamics of simulated pulmonary exposures of tigecycline alone and in combination against Klebsiella pneumoniae isolates producing a KPC carbapenemaseDora E Wiskirchen, Pornpan Koomanachai, Anthony M Nicasio, et al.
Antimicrobial Agents and Chemotherapy|October 6, 2010
Tissue penetration and pharmacokinetics of tigecycline in diabetic patients with chronic wound infections described by using in vivo microdialysisCatharine C Bulik, Dora E Wiskirchen, Ashley Shepard, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Antimicrobial Agents and Chemotherapy|October 19, 2011
In vitro pharmacodynamics of vancomycin and cefazolin alone and in combination against methicillin-resistant Staphylococcus aureusMao Hagihara, Dora E Wiskirchen, Joseph L Kuti, et al.
Pharmacotherapy|February 13, 2013
Comparative pharmacokinetics, pharmacodynamics, and tolerability of ertapenem 1 gram/day administered as a rapid 5-minute infusion versus the standard 30-minute infusion in healthy adult volunteersDora E Wiskirchen, Seth T Housman, Richard Quintiliani, et al.
Antimicrobial Agents and Chemotherapy|April 27, 2011
In vivo efficacy of a human-simulated regimen of ceftaroline combined with NXL104 against extended-spectrum-beta-lactamase (ESBL)-producing and non-ESBL-producing EnterobacteriaceaeDora E Wiskirchen, Jared L Crandon, Guilherme H Furtado, et al.
Antimicrobial Agents and Chemotherapy|February 2, 2011
In vitro pharmacodynamics of simulated pulmonary exposures of tigecycline alone and in combination against Klebsiella pneumoniae isolates producing a KPC carbapenemaseDora E Wiskirchen, Pornpan Koomanachai, Anthony M Nicasio, et al.
Antimicrobial Agents and Chemotherapy|October 6, 2010
Tissue penetration and pharmacokinetics of tigecycline in diabetic patients with chronic wound infections described by using in vivo microdialysisCatharine C Bulik, Dora E Wiskirchen, Ashley Shepard, et al.
Pageof 2